NASDAQ:TCRT - Nasdaq - US98973P3091 - Common Stock - Currency: USD
NASDAQ:TCRT (2/21/2025, 8:00:01 PM)
1.68
+0.07 (+4.35%)
The current stock price of TCRT is 1.68 USD. In the past month the price decreased by -17.65%. In the past year, price decreased by -91.3%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.97 | 357.10B | ||
AMGN | AMGEN INC | 15.29 | 162.72B | ||
GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
NTRA | NATERA INC | N/A | 21.43B | ||
BIIB | BIOGEN INC | 8.54 | 20.49B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Alaunos Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Houston, Texas and currently employs 1 full-time employees. The company went IPO on 2004-08-20. Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The firm is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
ALAUNOS THERAPEUTICS INC
2617 Bissonnet St, Suite 225
Houston TEXAS US
Employees: 1
Company Website: https://alaunos.com/
Investor Relations: https://ir.alaunos.com/
Phone: 13463554099
The current stock price of TCRT is 1.68 USD. The price increased by 4.35% in the last trading session.
The exchange symbol of ALAUNOS THERAPEUTICS INC is TCRT and it is listed on the Nasdaq exchange.
TCRT stock is listed on the Nasdaq exchange.
ALAUNOS THERAPEUTICS INC (TCRT) has a market capitalization of 2.69M USD. This makes TCRT a Nano Cap stock.
ALAUNOS THERAPEUTICS INC (TCRT) currently has 1 employees.
ALAUNOS THERAPEUTICS INC (TCRT) has a support level at 1.65 and a resistance level at 1.69. Check the full technical report for a detailed analysis of TCRT support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TCRT does not pay a dividend.
ALAUNOS THERAPEUTICS INC (TCRT) will report earnings on 2025-03-31, after the market close.
ALAUNOS THERAPEUTICS INC (TCRT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-22.9).
The outstanding short interest for ALAUNOS THERAPEUTICS INC (TCRT) is 4.76% of its float. Check the ownership tab for more information on the TCRT short interest.
ChartMill assigns a fundamental rating of 3 / 10 to TCRT. While TCRT seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months TCRT reported a non-GAAP Earnings per Share(EPS) of -22.9. The EPS increased by 15.19% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -331.86% | ||
ROE | -432.49% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to TCRT. The Buy consensus is the average rating of analysts ratings from 6 analysts.